Publications

Found 397 results
2016
Kleinsteuber K, Corleis B, Rashidi N, Nchinda N, Lisanti A, Cho JL, Medoff BD, Kwon D, Walker BD.  2016.  Standardization and quality control for high-dimensional mass cytometry studies of human samples.. Cytometry A. 89(10):903-913.
Halldorsson S, Behrens A-J, Harlos K, Huiskonen JT, Elliott RM, Crispin M, Brennan B, Bowden TA.  2016.  Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion.. Proc Natl Acad Sci U S A. 113(26):7154-9.
Tam HHei, Melo MB, Kang M, Pelet JM, Ruda VM, Foley MH, Hu JK, Kumari S, Crampton J, Baldeon AD et al..  2016.  Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination.. Proc Natl Acad Sci U S A. 113(43):E6639-E6648.
Nakaya HI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Patel NB, Zak DE, Aderem A, Dong T et al..  2016.  Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.. Proc Natl Acad Sci U S A. 113(7):1853-8.
Briney B, Sok D, Jardine JG, Kulp DW, Skog P, Menis S, Jacak R, Kalyuzhniy O, de Val N, Sesterhenn F et al..  2016.  Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.. Cell. 166(6):1459-1470.e11.
Bancroft T, Dillon MBC, Antunes Rda Silva, Paul S, Peters B, Crotty S, Arlehamn CSLindesta, Sette A.  2016.  Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.. Cell Immunol. 304-305:35-43.
Feng Y, Tran K, Bale S, Kumar S, Guenaga J, Wilson R, de Val N, Arendt H, DeStefano J, Ward AB et al..  2016.  Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies.. PLoS Pathog. 12(8):e1005767.
Halper-Stromberg A, Nussenzweig MC.  2016.  Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.. J Clin Invest. 126(2):415-23.
Harvey DJ, Scarff CA, Edgeworth M, Struwe WB, Pagel K, Thalassinos K, Crispin M, Scrivens J.  2016.  Travelling-wave ion mobility and negative ion fragmentation of high-mannose N-glycans.. J Mass Spectrom. 51(3):219-35.
Harvey DJ, Scarff CA, Edgeworth M, Pagel K, Thalassinos K, Struwe WB, Crispin M, Scrivens JH.  2016.  Travelling-wave ion mobility mass spectrometry and negative ion fragmentation of hybrid and complex N-glycans.. J Mass Spectrom.
Stewart-Jones GBE, Soto C, Lemmin T, Chuang G-Y, Druz A, Kong R, Thomas PV, Wagh K, Zhou T, Behrens A-J et al..  2016.  Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.. Cell. 165(4):813-26.
Kong L, He L, de Val N, Vora N, Morris CD, Azadnia P, Sok D, Zhou B, Burton DR, Ward AB et al..  2016.  Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability.. Nat Commun. 7:12040.
Larocca RA, Abbink P, Peron JPierre S, Zanotto PM de A, Iampietro JM, Badamchi-Zadeh A, Boyd M, Ng'ang'a D, Kirilova M, Nityanandam R et al..  2016.  Vaccine protection against Zika virus from Brazil.. Nature.
Iyer SS, Gangadhara S, Victor B, Shen X, Chen X, Nabi R, Kasturi SP, Sabula MJ, Labranche CC, Reddy PBJ et al..  2016.  Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.. J Virol. 90(19):8842-54.
Quicke KM, Bowen JR, Johnson EL, McDonald CE, Ma H, O'Neal JT, Rajakumar A, Wrammert J, Rimawi BH, Pulendran B et al..  2016.  Zika Virus Infects Human Placental Macrophages.. Cell Host Microbe. 20(1):83-90.
2015
Gardner MR, Kattenhorn LM, Kondur HR, von Schaewen M, Dorfman T, Chiang JJ, Haworth KG, Decker JM, Alpert MD, Bailey CC et al..  2015.  AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.. Nature. 519(7541):87-91.
Garces F, Lee J H, de Val N, de la Peña ATorrents, Kong L, Puchades C, Hua Y, Stanfield RL, Burton DR, Moore JP et al..  2015.  Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.. Immunity. 43(6):1053-63.
Lee J H, Leaman DP, Kim AS, de la Peña ATorrents, Sliepen K, Yasmeen A, Derking R, Ramos A, de Taeye SW, Ozorowski G et al..  2015.  Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike.. Nat Commun. 6:8167.
Wieland A, Shashidharamurthy R, Kamphorst AO, Han J-H, Aubert RD, Choudhury BP, Stowell SR, Lee J, Punkosdy GA, Shlomchik MJ et al..  2015.  Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.. Immunity. 42(2):367-78.
Burton DR, Mascola JR.  2015.  Antibody responses to envelope glycoproteins in HIV-1 infection.. Nat Immunol. 16(6):571-6.
Lee WShi, Richard J, Lichtfuss M, Smith AB, Park J, Courter JR, Melillo BN, Sodroski JG, Kaufmann DE, Finzi A et al..  2015.  Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.. J Virol. 90(4):2021-30.
He L, Cheng Y, Kong L, Azadnia P, Giang E, Kim J, Wood MR, Wilson IA, Law M, Zhu J.  2015.  Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding.. Sci Rep. 5:12501.
Hatzi K, J Nance P, Kroenke MA, Bothwell M, Haddad EK, Melnick A, Crotty S.  2015.  BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms.. J Exp Med. 212(4):539-53.
Crotty S.  2015.  A brief history of T cell help to B cells.. Nat Rev Immunol. 15(3):185-9.
Radebe M, Gounder K, Mokgoro M, Ndhlovu ZM, Mncube Z, Mkhize L, van der Stok M, Jaggernath M, Walker BD, Ndung'u T.  2015.  Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.. AIDS. 29(1):23-33.

Pages